Cargando…
Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Ea...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531613/ https://www.ncbi.nlm.nih.gov/pubmed/32970482 http://dx.doi.org/10.1200/CCI.20.00023 |
_version_ | 1783589789541335040 |
---|---|
author | Nilanon, Tanachat Nocera, Luciano P. Martin, Alexander S. Kolatkar, Anand May, Marcella Hasnain, Zaki Ueno, Naoto T. Yennu, Sriram Alexander, Angela Mejia, Aaron E. Boles, Roger Wilson Li, Ming Lee, Jerry S. H. Hanlon, Sean E. Cozzens Philips, Frankie A. Quinn, David I. Newton, Paul K. Broderick, Joan Shahabi, Cyrus Kuhn, Peter Nieva, Jorge J. |
author_facet | Nilanon, Tanachat Nocera, Luciano P. Martin, Alexander S. Kolatkar, Anand May, Marcella Hasnain, Zaki Ueno, Naoto T. Yennu, Sriram Alexander, Angela Mejia, Aaron E. Boles, Roger Wilson Li, Ming Lee, Jerry S. H. Hanlon, Sean E. Cozzens Philips, Frankie A. Quinn, David I. Newton, Paul K. Broderick, Joan Shahabi, Cyrus Kuhn, Peter Nieva, Jorge J. |
author_sort | Nilanon, Tanachat |
collection | PubMed |
description | PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS: We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 am to 8 pm for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 am to 8 pm hours with > 1.5 METs as nonsedentary physical activity hours. RESULTS: Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION: The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs. |
format | Online Article Text |
id | pubmed-7531613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-75316132021-09-24 Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters Nilanon, Tanachat Nocera, Luciano P. Martin, Alexander S. Kolatkar, Anand May, Marcella Hasnain, Zaki Ueno, Naoto T. Yennu, Sriram Alexander, Angela Mejia, Aaron E. Boles, Roger Wilson Li, Ming Lee, Jerry S. H. Hanlon, Sean E. Cozzens Philips, Frankie A. Quinn, David I. Newton, Paul K. Broderick, Joan Shahabi, Cyrus Kuhn, Peter Nieva, Jorge J. JCO Clin Cancer Inform ORIGINAL REPORTS PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS: We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 am to 8 pm for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 am to 8 pm hours with > 1.5 METs as nonsedentary physical activity hours. RESULTS: Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION: The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs. American Society of Clinical Oncology 2020-09-24 /pmc/articles/PMC7531613/ /pubmed/32970482 http://dx.doi.org/10.1200/CCI.20.00023 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | ORIGINAL REPORTS Nilanon, Tanachat Nocera, Luciano P. Martin, Alexander S. Kolatkar, Anand May, Marcella Hasnain, Zaki Ueno, Naoto T. Yennu, Sriram Alexander, Angela Mejia, Aaron E. Boles, Roger Wilson Li, Ming Lee, Jerry S. H. Hanlon, Sean E. Cozzens Philips, Frankie A. Quinn, David I. Newton, Paul K. Broderick, Joan Shahabi, Cyrus Kuhn, Peter Nieva, Jorge J. Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title | Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title_full | Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title_fullStr | Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title_full_unstemmed | Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title_short | Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters |
title_sort | use of wearable activity tracker in patients with cancer undergoing chemotherapy: toward evaluating risk of unplanned health care encounters |
topic | ORIGINAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531613/ https://www.ncbi.nlm.nih.gov/pubmed/32970482 http://dx.doi.org/10.1200/CCI.20.00023 |
work_keys_str_mv | AT nilanontanachat useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT noceralucianop useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT martinalexanders useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT kolatkaranand useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT maymarcella useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT hasnainzaki useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT uenonaotot useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT yennusriram useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT alexanderangela useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT mejiaaarone useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT bolesrogerwilson useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT liming useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT leejerrysh useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT hanlonseane useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT cozzensphilipsfrankiea useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT quinndavidi useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT newtonpaulk useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT broderickjoan useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT shahabicyrus useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT kuhnpeter useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters AT nievajorgej useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters |